An open label multi facilities cooperation randomized control trial to verify renoprotective effects of improvement in postprandial hyperglycemia in diabetic nephropathy.

Trial Profile

An open label multi facilities cooperation randomized control trial to verify renoprotective effects of improvement in postprandial hyperglycemia in diabetic nephropathy.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 May 2016

At a glance

  • Drugs Mitiglinide (Primary) ; Glimepiride
  • Indications Diabetic nephropathies; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2011 Planned End Date changed from 1 Apr 2015 to 1 Sep 2015 as reported by University Hospital Medical Information Network - Japan.
    • 25 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top